|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
1994-4-29
|
|
pubmed:abstractText |
A case of uterine rupture caused by extraovular PGE2 in a sequence with intravenous oxytocin during midtrimester termination of pregnancy is presented. It teaches us that when oxytocin is used after prostaglandins in patients having a scarred uterus, the lowest effective dose should be applied.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0267-4874
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
9
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
331-3
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:8147247-Abortion, Therapeutic,
pubmed-meshheading:8147247-Adult,
pubmed-meshheading:8147247-Dinoprostone,
pubmed-meshheading:8147247-Female,
pubmed-meshheading:8147247-Fetal Death,
pubmed-meshheading:8147247-Humans,
pubmed-meshheading:8147247-Oxytocin,
pubmed-meshheading:8147247-Pregnancy,
pubmed-meshheading:8147247-Pregnancy Trimester, Second,
pubmed-meshheading:8147247-Uterine Rupture
|
|
pubmed:year |
1993
|
|
pubmed:articleTitle |
Extraovular PGE2 and oxytocin-implicated uterine rupture during midtrimester termination of pregnancy.
|
|
pubmed:affiliation |
Department of Obstetrics and Gynecology, Kaplan Hospital, Rehovot, Israel.
|
|
pubmed:publicationType |
Journal Article,
Case Reports
|
